ASX - By Stock
|
RCE |
Re:
Ann: Patent Granted in Israel for RECCE Anti-Infectives
|
|
Chatterbox
|
8 |
2.9K |
8 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
8
|
2.9K
|
8
|
|
ASX - By Stock
|
ADO |
Re:
2024 - The year of ADO
|
|
Chatterbox
|
727 |
230K |
55 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
727
|
230K
|
55
|
|
ASX - By Stock
|
ADO |
Re:
ferroglobe-accuses-asx-company-of-using-confidential-ip-after-failed-collaboration
|
|
Chatterbox
|
702 |
257K |
6 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
702
|
257K
|
6
|
|
ASX - By Stock
|
ADO |
Re:
Do it again
|
|
Chatterbox
|
53 |
16K |
26 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
53
|
16K
|
26
|
|
ASX - By Stock
|
IMU |
City of Hope cancer treatment
|
|
Chatterbox
|
47 |
24K |
6 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
47
|
24K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Up strongly on no news
|
|
Chatterbox
|
41 |
15K |
7 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
41
|
15K
|
7
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 31 March 2023
|
|
Chatterbox
|
102 |
35K |
0 |
25/04/23 |
25/04/23 |
ASX - By Stock
|
102
|
35K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 31 March 2023
|
|
Chatterbox
|
102 |
35K |
1 |
25/04/23 |
25/04/23 |
ASX - By Stock
|
102
|
35K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 31 March 2023
|
|
Chatterbox
|
102 |
35K |
4 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
102
|
35K
|
4
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
Chatterbox
|
9.1K |
2.7M |
0 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
9.1K
|
2.7M
|
0
|
|
ASX - By Stock
|
ADO |
Re:
battery update this week?
|
|
Chatterbox
|
241 |
78K |
25 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
241
|
78K
|
25
|
|
ASX - By Stock
|
ADO Technology |
Re:
What is the relevance of Anteo’s battery data?
|
|
Chatterbox
|
500 |
384K |
0 |
28/06/22 |
28/06/22 |
ASX - By Stock
|
500
|
384K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Recce Pharmaceuticals (ASX:RCE): A multi-billion-dollar sepsis solution?
|
|
Chatterbox
|
27 |
16K |
6 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
27
|
16K
|
6
|
|
ASX - By Stock
|
RCE |
Burns trial report?
|
|
Chatterbox
|
0 |
690 |
7 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
0
|
690
|
7
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive safety data from 4th Cohort -Phase I Clinical Trial
|
|
Chatterbox
|
20 |
8.1K |
4 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
20
|
8.1K
|
4
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Chatterbox
|
2.1K |
625K |
1 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
2.1K
|
625K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Investor Update Webinar Invitation
|
|
Chatterbox
|
543 |
182K |
14 |
10/03/22 |
10/03/22 |
ASX - By Stock
|
543
|
182K
|
14
|
|
ASX - By Stock
|
CYP |
Re:
BREAKTHROUGH, WORLD FIRST CRITICAL ANTIBIOTIC TREATMENT
|
|
Chatterbox
|
7 |
2.1K |
0 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
7
|
2.1K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
BREAKTHROUGH, WORLD FIRST CRITICAL ANTIBIOTIC TREATMENT
|
|
Chatterbox
|
7 |
2.1K |
1 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
7
|
2.1K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
BREAKTHROUGH, WORLD FIRST CRITICAL ANTIBIOTIC TREATMENT
|
|
Chatterbox
|
7 |
2.1K |
0 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
7
|
2.1K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Safety Continues in 3rd Cohort PhI Clinical Trial
|
|
Chatterbox
|
56 |
19K |
1 |
26/02/22 |
26/02/22 |
ASX - By Stock
|
56
|
19K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Ann: TGA Registration Update
|
|
Chatterbox
|
550 |
167K |
57 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
550
|
167K
|
57
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Safety Data from Third Cohort of PI Clinical Trial
|
|
Chatterbox
|
37 |
9.8K |
7 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
37
|
9.8K
|
7
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Safety Data from Third Cohort of PI Clinical Trial
|
|
Chatterbox
|
37 |
9.8K |
5 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
37
|
9.8K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Safety Data from Third Cohort of PI Clinical Trial
|
|
Chatterbox
|
37 |
9.8K |
2 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
37
|
9.8K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Chatterbox
|
216 |
61K |
16 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
216
|
61K
|
16
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Chatterbox
|
216 |
61K |
90 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
216
|
61K
|
90
|
|
ASX - By Stock
|
ADO |
Re:
Ann: TGA Registration Update
|
|
Chatterbox
|
504 |
146K |
20 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
504
|
146K
|
20
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Chatterbox
|
2.1K |
625K |
5 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
2.1K
|
625K
|
5
|
|
ASX - By Stock
|
ADO |
Re:
Ann: TGA Registration Update
|
|
Chatterbox
|
2.4K |
723K |
37 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
2.4K
|
723K
|
37
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection
|
|
Chatterbox
|
103 |
29K |
5 |
10/12/21 |
10/12/21 |
ASX - By Stock
|
103
|
29K
|
5
|
|
ASX - By Stock
|
ADO |
Re:
Ellume looking to List
|
|
Chatterbox
|
39 |
12K |
16 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
39
|
12K
|
16
|
|
ASX - By Stock
|
ADO |
Re:
Trademarks
|
|
Chatterbox
|
22 |
9.9K |
3 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
22
|
9.9K
|
3
|
|
ASX - By Stock
|
ADO Energy |
Re:
Battery Market
|
|
Chatterbox
|
9 |
3.5K |
33 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
9
|
3.5K
|
33
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Chatterbox
|
196 |
55K |
1 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
196
|
55K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Complete Regression of TNBC Tumours and Protective Immunity
|
|
Chatterbox
|
279 |
125K |
4 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
279
|
125K
|
4
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Chatterbox
|
369 |
105K |
8 |
14/10/21 |
14/10/21 |
ASX - By Stock
|
369
|
105K
|
8
|
|
ASX - By Stock
|
ADO |
Re:
Tesla's new battery tech has more silicon
|
|
Chatterbox
|
28 |
11K |
3 |
27/09/21 |
27/09/21 |
ASX - By Stock
|
28
|
11K
|
3
|
|
ASX - By Stock
|
ADO |
Re:
Webinar
|
|
Chatterbox
|
178 |
56K |
20 |
25/09/21 |
25/09/21 |
ASX - By Stock
|
178
|
56K
|
20
|
|
ASX - By Stock
|
ADO |
Re:
Webinar
|
|
Chatterbox
|
178 |
56K |
23 |
24/09/21 |
24/09/21 |
ASX - By Stock
|
178
|
56K
|
23
|
|
ASX - By Stock
|
ADO |
Re:
EuGeni
|
|
Chatterbox
|
2.6K |
794K |
2 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
2.6K
|
794K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
EuGeni
|
|
Chatterbox
|
2.6K |
794K |
0 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
2.6K
|
794K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
SP . Price movement
|
|
Chatterbox
|
3.3K |
1.1M |
0 |
04/07/21 |
04/07/21 |
ASX - By Stock
|
3.3K
|
1.1M
|
0
|
|
ASX - By Stock
|
ADO |
Re:
Pre AGM Share price prediction. EOD Friday 5th Nov 2021
|
|
Chatterbox
|
136 |
52K |
2 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
136
|
52K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Initial Proof-of-Concept results show INV043 to be effective
|
|
Chatterbox
|
49 |
24K |
1 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
49
|
24K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Urgent need for Sepsis tests by ADO
|
|
Chatterbox
|
46 |
16K |
1 |
10/06/21 |
10/06/21 |
ASX - By Stock
|
46
|
16K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Urgent need for Sepsis tests by ADO
|
|
Chatterbox
|
46 |
16K |
4 |
10/06/21 |
10/06/21 |
ASX - By Stock
|
46
|
16K
|
4
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Chatterbox
|
2.1K |
625K |
3 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
2.1K
|
625K
|
3
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech raises $8.0m in strongly supported SPP
|
|
Chatterbox
|
241 |
79K |
2 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
241
|
79K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech raises $8.0m in strongly supported SPP
|
|
Chatterbox
|
241 |
79K |
2 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
241
|
79K
|
2
|
|